Travere Therapeutics ($TVTX) Insider Trading & Smart Money Activity

Travere Therapeutics, Inc. · Biotechnology · Latest filing Jun 25, 2026

Travere Therapeutics, Inc. ($TVTX) has 4 insider trades and 5 analyst ratings on file. Insiders filed 4 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

5

TVTX insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All TVTX insider, congress, 13F and analyst activity

All Insiders Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 25, 2026	Analyst	Guggenheim	Reiterates to buy		PT $65		-3.6%	-4.0%			Read
Jun 22, 2026	Analyst	Wedbush	Reiterates to buy		PT $61		+5.8%	+2.1%			Read
Jun 22, 2026	Insider	Jula InrigCHIEF MEDICAL OFFICER	Sell (Gift)	468 sh			+5.8%	+2.1%			—
Jun 18, 2026	Analyst	Evercore ISI Group	Reiterates to buy		PT $60		+7.0%	+0.6%			Read
Jun 15, 2026	Analyst	Citigroup	Reiterates to buy		PT $70		+2.4%	+5.5%			Read
Jun 12, 2026	Analyst	Wells Fargo	Reiterates to buy		PT $65		+5.9%	+8.2%			Read
Jun 12, 2026	Insider	Timothy Coughlin	Sell (Option exercise)	10K sh			+5.9%	+8.2%			—
Jun 12, 2026	Insider	Roy Baynes	Sell (Option exercise)	4.50K sh			+5.9%	+8.2%			Read
Jun 12, 2026	Insider	Roy Baynes	Buy (Option exercise)	4.50K sh	$96.21K		+5.9%	+8.2%			Read

1W / 1M / 6M = how TVTX moved from the trade or filing date.

Insider trading in TVTX: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Jula Inrig	CHIEF MEDICAL OFFICER	1	—		Jun 22, 2026
Roy Baynes		2	—		Jun 12, 2026
Timothy Coughlin		1	—		Jun 12, 2026

Analyst ratings on TVTX

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 25, 2026	Guggenheim	Reiterates	buy	$65	-3.6%	-4.0%		Read
Jun 22, 2026	Wedbush	Reiterates	buy	$61	+5.8%	+2.1%		Read
Jun 18, 2026	Evercore ISI Group	Reiterates	buy	$60	+7.0%	+0.6%		Read
Jun 15, 2026	Citigroup	Reiterates	buy	$70	+2.4%	+5.5%		Read
Jun 12, 2026	Wells Fargo	Reiterates	buy	$65	+5.9%	+8.2%		Read

Frequently asked questions

What is the latest insider trade in TVTX?

Jula Inrig, CHIEF MEDICAL OFFICER filed a sell (gift) of 468 sh on Jun 22, 2026.

Other biotechnology stocks

• $MIRM
• $SRRK
• $LGND
• $TERN
• $CNTA
• $COGT
• $DNTH
• $DFTX

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.